Logo
Logo

About Rivastigmine Hydrogen Tartrate API

Product
  • Therapeutic CategoryCentral Nervous System (CNS)

  • CAS Number

    129101-54-8

  • API Technology

    Synthetic

  • Dose Form

    Film (Transdermal), Oral Solid/Capsules

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted, EUDMF, China DMF

Mechanism of Action

Rivastigmine is a type of medicine called an acetylcholinesterase inhibitor. It works by slowing the breakdown of a neurotransmitter in the brain called acetylcholine.

Indication

EXELON is an acetylcholinesterase inhibitor indicated for treatment of:

  • Mild to moderate dementia of the Alzheimer’s type
  • Mild to moderate dementia associated with Parkinson’s disease

Related APIs

Eslicarbazepine Acetate

Central Nervous System (CNS)

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.